Spots Global Cancer Trial Database for A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.
Official Title: A Multicenter, Randomized, Open Label Dose Finding Study of Mircera in Anemic Patients With Stage IIIB or IV Non-small Cell Lung Cancer Receiving First Line Myelosuppressive Chemotherapy
Study ID: NCT00327535
Conditions
Study Description
Brief Summary: This 4 arm study will assess the optimal starting dose of Mircera in the treatment of anemia in patients with non-small cell lung cancer receiving first line myelosuppressive chemotherapy. Patients will be randomized to receive either Mircera 6.3 micrograms/kg, 9 micrograms/kg or 12 micrograms/kg s.c. every 3 weeks or darbepoetin alfa according to the approved local label (either 6.75 micrograms/kg s.c. every 3 weeks, or 2.25 micrograms/kg every week). The anticipated time on study treatment is \<3 months and the target sample size is 100-500 individuals.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, East Bentleigh, , Australia
, Kurralta Park, , Australia
, Milton, , Australia
, Linz, , Austria
, Salzburg, , Austria
, Wien, , Austria
, Wien, , Austria
, Wien, , Austria
, Aalst, , Belgium
, Edegem, , Belgium
, Liege, , Belgium
, Toronto, Ontario, Canada
, Toronto, Ontario, Canada
, Brno, , Czech Republic
, Hradec Kralove, , Czech Republic
, Ostrava, , Czech Republic
, Praha, , Czech Republic
, Tallin, , Estonia
, Tartu, , Estonia
, Helsinki, , Finland
, Bobigny, , France
, Caen, , France
, Dijon, , France
, Lyon, , France
, Paris, , France
, Pessac, , France
, Pierre Benite, , France
, Saint Pierre, , France
, Gauting, , Germany
, Hamburg, , Germany
, Hamburg, , Germany
, Heidelberg, , Germany
, Karlsruhe, , Germany
, Trier, , Germany
, Athens, , Greece
, Heraklion, , Greece
, Larissa, , Greece
, Thessaloniki, , Greece
, Thessaloniki, , Greece
, Hong Kong, , Hong Kong
, Hong Kong, , Hong Kong
, Budapest, , Hungary
, Deszk, , Hungary
, Mátraháza, , Hungary
, Nyiregyhaza, , Hungary
, Szekesfehervar, , Hungary
, Genova, , Italy
, Legnago, , Italy
, Novara, , Italy
, Pavia, , Italy
, Ravenna, , Italy
, San Giovanni Rotondo, , Italy
, Sassari, , Italy
, Bydgoszcz, , Poland
, Elblag, , Poland
, Otwock, , Poland
, Poznan, , Poland
, Radom, , Poland
, Wloclawek, , Poland
, Wroclaw, , Poland
, Barcelona, , Spain
, Barcelona, , Spain
, Girona, , Spain
, La Laguna, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Zaragoza, , Spain
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
